![Patricia Chienfang Kao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patricia Chienfang Kao
Algemeen Directeur bij SVB Asset Management
Profiel
Patricia Chienfang Kao is currently the President, Chief Executive Officer & Director at SVB Asset Management.
She completed her undergraduate degree at the University of California, Berkeley and her MBA at MIT Sloan School of Management.
Actieve functies van Patricia Chienfang Kao
Bedrijven | Functie | Begin |
---|---|---|
SVB Asset Management
![]() SVB Asset Management Investment ManagersFinance SVB Asset Management is a SEC-registered investment advisor headquartered in San Francisco, California. The firm was founded in 2002 and is a wholly-owned subsidiary of First-Citizens Bank & Trust Co., which in turn, is a wholly owned subsidiary of First Citizens BancShares, Inc. (NASDAQ: FCNCA). SVB Asset Management provides discretionary investment management services for corporate clients in the innovation economy, specifically in the technology and life science/healthcare industries. | Algemeen Directeur | - |
Opleiding van Patricia Chienfang Kao
MIT Sloan School of Management | Masters Business Admin |
University of California, Berkeley | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
SVB Asset Management
![]() SVB Asset Management Investment ManagersFinance SVB Asset Management is a SEC-registered investment advisor headquartered in San Francisco, California. The firm was founded in 2002 and is a wholly-owned subsidiary of First-Citizens Bank & Trust Co., which in turn, is a wholly owned subsidiary of First Citizens BancShares, Inc. (NASDAQ: FCNCA). SVB Asset Management provides discretionary investment management services for corporate clients in the innovation economy, specifically in the technology and life science/healthcare industries. | Finance |